SEC Form 4 · accession 0001179110-19-002152
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sammy Karam
Officer — Senior Vice President
Period of report
Feb 16, 2019
Accepted (ET)
Feb 20, 2019 · 5:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par valueF1 | Feb 16, 2019 | F | 814 | $75.25 | D | 17,853 | D | |
| Common shares without par value | Feb 17, 2019 | F | 771 | $75.25 | D | 17,082 | D | |
| Common shares without par value | Feb 19, 2019 | F | 792 | $75.25 | D | 16,290 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes shares acquired under the Abbott Laboratories 2017 Employee Stock Purchase Plan for Non-U.S. Employees.